>> in other words the time was set before the trial <<
Thanks Peter. For the gleason < 7 population, pre-defined?
Somewhere, ages ago here at SI (the BVF thread?), I gave my opinion that, if one cancer vaccine trial looked interesting, it was provenge.
When we get enough of this data, full-blown and lotsa patients, we'll know if any survival advantage is just a modest adjuvant effect or if it's due to immunization against a "cancer antigen". Cytotoxic T cells can chew into Ft. Knox. To me, a modestly displaced survival curve without a significant increase in long-term survivors means squat.
Haven't looked at the project in ages, didn't listen to the call, haven't even read the release. Trying to clear Red Sox celebration.
We've got some new contributors, would be good to hear their views. Just throwing the post out as fodder.
Congratulations, rkrw!! The rest of us are just rookies. |
